PRIMA-1(MET) induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells

There is an intensive need for the development of novel drugs for the treatment of epithelial ovarian cancer (EOC), the most lethal gynecologic malignancy due to the high recurrence rate. TP53 mutation is a common event in EOC, particularly in high-grade serous ovarian cancer, where it occurs in mor...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncol Rep
Main Authors: YOSHIKAWA, NOBUHISA, KAJIYAMA, HIROAKI, NAKAMURA, KAE, UTSUMI, FUMI, NIIMI, KAORU, MITSUI, HIROKO, SEKIYA, RYUICHIRO, SUZUKI, SHIRO, SHIBATA, KIYOSUMI, CALLEN, DAVID, KIKKAWA, FUMITAKA
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2016
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4811399/
https://ncbi.nlm.nih.gov/pubmed/26986846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2016.4653
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים